Pharmacists granted power to limit supply of 3 ‘high demand’ HRT products

Pharmacists will be able to limit the supply of HRT products Oestrogel, Ovestin cream and Premique Low Dose to three months, regardless of the prescription, without needing to seek authorisation from the prescriber.

breaking
It is hoped the measures will help women "access the HRT they need" • Source: Community Pharmacy Workforce Development Group, Boots (September, 2021)

Health secretary Sajid Javid has today (April 29) issued serious shortage protocols (SSPs) for the three “high demand” hormone replacement therapy (HRT) products “to ensure women are able to access the HRT they need”.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Clinical

exclusive

Paydens reveals rollout of ‘same-day’ private prescribing service

 
• By 
 • comment

Paydens Pharmacy has announced the rollout of a private prescribing service that allows patients to access same-day care “without needing to see their GP” for £15 per consultation.

Boots to ‘review processes’ after caught dispensing Wegovy to teen

 
• By 
 • comment

The health secretary has deemed Boots weight loss safeguards “totally unacceptable” after a new Dispatches documentary found that the pharmacy provided a 16-year-old with Wegovy against its own policy.